Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Semicircular canal dehiscence (SCD) syndrome is a rare otorhinolaryngologic disease characterized by the uni- or bilateral dehiscence of the bone(s) overlying the superior (most common), lateral or posterior semicircular canal(s). Patients present audiological (autophony, aural fullness, conductive hearing loss, pulsatile tinnitus) and/or vestibular symptoms (sound or pressure-evoked oscillopsia or vertigo, characteristic vertical-torsional eye movements), depending on which semicircular canal is affected. Posterior SCD syndrome is associated with high-riding jugular bulb and fibrous dysplasia, while lateral SCD syndrome is associated with chronic otitis media and cholesteatoma, with or without audiological and vestibular symptoms.
Biomarker and diagnostic research for semicircular canal dehiscence syndrome has been reported in the published literature.
Estimated prevalence: Unknown (Unknown prevalence).
1 clinical trial registered. Interventions under study include other interventions. Pipeline includes 1 NA. Research is primarily sponsored by academic and government institutions.
125 publications have been identified in PubMed for semicircular canal dehiscence syndrome. Kisho has analyzed 81 by research type. Research spans Review / Meta-Analysis (64%), Basic Science / Preclinical (11%), and Case Report / Case Series (7%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 52 |
Data assembled from 4 of 12 sources · Last updated Sep 19, 2026, 3:05 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Laboratory research | 9 | 11% |
Patient case studies | 6 | 7% |
Disease patterns and progression | 6 | 7% |
Testing and diagnosis research | 3 | 4% |
Clinical study results | 3 | 4% |
Other research | 1 | 1% |
New treatment approaches | 1 | 1% |
Ichijo H (2026). [PMID: 41782566](https://pubmed.ncbi.nlm.nih.gov/41782566/). *Acta Otolaryngol*. [Review / Meta-Analysis]
Benoit C (2026). [PMID: 39812476](https://pubmed.ncbi.nlm.nih.gov/39812476/). *Acta Otolaryngol*. [Review / Meta-Analysis]
Anderson EN (2026). [PMID: 41468891](https://pubmed.ncbi.nlm.nih.gov/41468891/). *Am J Hum Genet*. [Basic Science / Preclinical]
Lam CM (2026). [PMID: 41058020](https://pubmed.ncbi.nlm.nih.gov/41058020/). *Otol Neurotol*. [Clinical Trial Publication]
Zou J (2026). [PMID: 40956330](https://pubmed.ncbi.nlm.nih.gov/40956330/). *Eur Arch Otorhinolaryngol*. [Clinical Trial Publication]
Mat Q (2026). [PMID: 41897601](https://pubmed.ncbi.nlm.nih.gov/41897601/). *Diagnostics (Basel)*. [Diagnostic / Biomarker]
Lu L (2026). [PMID: 41949486](https://pubmed.ncbi.nlm.nih.gov/41949486/). *Acta Otolaryngol*. [Other]
Urichuk M (2026). [PMID: 41911291](https://pubmed.ncbi.nlm.nih.gov/41911291/). *J Otolaryngol Head Neck Surg*. [Review / Meta-Analysis]
Sahoo SS (2025). [PMID: 39475954](https://pubmed.ncbi.nlm.nih.gov/39475954/). *Blood*. [Review / Meta-Analysis]
Dotan A (2025). [PMID: 39931017](https://pubmed.ncbi.nlm.nih.gov/39931017/). *Harefuah*. [Review / Meta-Analysis]